Pharmaceutical firm GlaxoSmithKline (GSK) has confirmed job losses at one of its UK sites.
It is believed about 200 roles will be cut at the facility in Barnard Castle, County Durham, in October 2025.
The team affected has been producing the antibiotic Zinnat for the Swiss-owned firm Sandoz.
GSK said the vast majority of its staff at Barnard Castle were unaffected and that its first priority was to provide “comprehensive support” for those impacted.
The firm had said in 2021 that its Zinnat operations would be terminated when its contract with Sandoz ended “in the absence of any other alternative”.
It has now confirmed Sandoz has decided not to renew its contract.
The move comes as GSK confirmed it was shutting its site at Ulverston, Cumbria, which has also been producing the antibiotic for Sandoz.
A GSK spokesperson said Barnard Castle remained a key location where it manufactured some of its most “innovative medicines”.
Lloyds Banking Group is planning to hire hundreds of engineers in India as the company plans to shift its employment opportunit
£1.6m Music Export Growth Scheme to support 58 independent UK artists to tour the world Funding will boost UK’s creative industries – a key growth se
A BELOVED restaurant chain has announced it will close eight venues across the UK, scrapping 158 jobs in the process.Owners are pointing the finger at Labour's
The latest figures published by the US Bureau of Labor Statistics today (7 March) came in below market expectations, with economists polled by